Practical recommendations for the use of therapeutic drug monitoring of biopharmaceuticals in inflammatory diseases
Erwin Dreesen,1 Peter Bossuyt,2,3 Denis Mulleman,4 Ann Gils,1 Dora Pascual-Salcedo5 1Laboratory for Therapeutic and Diagnostic Antibodies, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, 2Imelda GI Clinical Research Centre, Imelda Ziekenhuis, Bonheiden, 3Translational R...
Saved in:
Main Authors: | Dreesen E (Author), Bossuyt P (Author), Mulleman D (Author), Gils A (Author), Pascual-Salcedo D (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2017-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Editorial: Therapeutic Drug Monitoring (TDM): A Useful Tool for Pediatric Pharmacology Applied to Routine Clinical Practice
by: Raffaele Simeoli, et al.
Published: (2022) -
Recommendations for the ethical conduct of vaccination awareness campaigns by biopharmaceutical companies
by: Claar van der Zee, et al.
Published: (2022) -
Advances in Therapeutic Drug Monitoring in Biologic Therapies for Pediatric Inflammatory Bowel Disease
by: Akshay Kapoor, et al.
Published: (2021) -
New Frontiers in Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease and Other Immune-Mediated Inflammatory Diseases
Published: (2023) -
Potential Role of Methotrexate Polyglutamates in Therapeutic Drug Monitoring for Pediatric Inflammatory Bowel Disease
by: Ryan Morrow, et al.
Published: (2021)